Zacks Investment Research upgraded shares of STERIS CORP (STE) from NEUTRAL to OUTPERFORM on August 14, 2012, with a target price of $37.00.
STERIS Corporation is a leading provider of infection prevention, contamination prevention, and surgical support systems, products, services, and technologies to healthcare, scientific, research, and industrial Customers throughout the world. The Company has over 4,000 Associates (employees) worldwide, including more than 1,200 direct sales, service, and field support personnel. Customer Support facilities are located in major global market centers with manufacturing operations in the United States, Canada, Germany, and Finland.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on STERIS CORP (STE),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment